You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

OPTICROM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Opticrom, and what generic alternatives are available?

Opticrom is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in OPTICROM is cromolyn sodium. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Opticrom

A generic version of OPTICROM was approved as cromolyn sodium by SANDOZ on June 16th, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OPTICROM?
  • What are the global sales for OPTICROM?
  • What is Average Wholesale Price for OPTICROM?
Summary for OPTICROM
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 98
Patent Applications: 4,783
DailyMed Link:OPTICROM at DailyMed
Drug patent expirations by year for OPTICROM

US Patents and Regulatory Information for OPTICROM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan OPTICROM cromolyn sodium SOLUTION/DROPS;OPHTHALMIC 018155-001 Oct 3, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for OPTICROM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan OPTICROM cromolyn sodium SOLUTION/DROPS;OPHTHALMIC 018155-001 Oct 3, 1984 ⤷  Sign Up ⤷  Sign Up
Allergan OPTICROM cromolyn sodium SOLUTION/DROPS;OPHTHALMIC 018155-001 Oct 3, 1984 ⤷  Sign Up ⤷  Sign Up
Allergan OPTICROM cromolyn sodium SOLUTION/DROPS;OPHTHALMIC 018155-001 Oct 3, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for OPTICROM

See the table below for patents covering OPTICROM around the world.

Country Patent Number Title Estimated Expiration
Denmark 131324 ⤷  Sign Up
Netherlands 147732 ⤷  Sign Up
Israel 39286 PHARMACEUTICAL COMPOSITIONS COMPRISING A CLEAR AQUEOUS SOLUTION OF A 1,3-BIS(CHROMON-5-YLOXY)-PROPAN-2-OL DERIVATIVE OR A SALT THEREOF ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.